Aspira Women's Health Inc.

OTC:AWHL

In Vitro & In Vivo Diagnostic Substances·AUSTIN, TX

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/19/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/19/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
11/14/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/19/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
↓

News (8-K)

64 shown

Filed	Type	Description
1/30/26	Agreement	Entry into a Material Definitive Agreement	→
12/31/25	Reg FD	Regulation FD Disclosure	→
12/23/25	Agreement	Entry into a Material Definitive Agreement	→
12/22/25	Agreement	Entry into a Material Definitive Agreement	→
11/3/25	Agreement	Entry into a Material Definitive Agreement	→
10/15/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/12/26	424B3	424B3	→
12/31/25	S-1	S-1	→
11/21/25	424B3	424B3	→
10/20/25	S-1/A	S-1/A	→
9/30/25	S-1	S-1	→
6/9/25	S-8	S-8	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

8-K

Jan 30, 2026

0000926617-26-0000078-K

Jan 30, 2026

542.5 KB

424B3

Jan 12, 2026

0001104659-26-002556424B3

—

325.3 KB

EFFECT

Jan 9, 2026

9999999995-26-000142

—

2.0 KB

S-1

Dec 31, 2025

0000926617-25-000018S-1

—

556.8 KB

8-K

Dec 31, 2025

0000926617-25-0000148-K

Dec 29, 2025

10.1 MB

8-K

Dec 23, 2025

0001104659-25-1242458-K

Dec 23, 2025

664.5 KB

8-K

Dec 22, 2025

0000926617-25-0000108-K

Dec 16, 2025

144.0 KB

Dec 4, 2025

0001493152-25-0261194

Dec 2, 2025

5.4 KB

Dec 4, 2025

0001493152-25-0261104

Dec 2, 2025

5.4 KB

Dec 3, 2025

0001493152-25-0260784

Dec 2, 2025

5.4 KB

Dec 3, 2025

0001493152-25-0260764

Dec 2, 2025

5.4 KB

Dec 3, 2025

0001493152-25-0260744

Dec 2, 2025

5.4 KB

Dec 3, 2025

0001493152-25-0260714

Dec 2, 2025

5.4 KB

EFFECT

Nov 21, 2025

9999999995-25-003345

—

2.0 KB

424B3

Nov 21, 2025

0001104659-25-115034424B3

—

436.5 KB

10-Q

Nov 14, 2025

0000926617-25-00000810-Q

Sep 30, 2025

8.6 MB

8-K

Nov 14, 2025

0000926617-25-0000048-K

Nov 14, 2025

387.1 KB

8-K/A

Nov 3, 2025

0001104659-25-1055618-K/A

Sep 19, 2025

305.7 KB

S-1/A

Oct 20, 2025

0001493152-25-018669S-1/A

—

475.1 KB

8-K

Oct 15, 2025

0001493152-25-0181468-K

Oct 14, 2025

191.8 KB

S-1

Sep 30, 2025

0001493152-25-016373S-1

—

460.0 KB

8-K

Sep 25, 2025

0001493152-25-0149258-K

Sep 19, 2025

393.9 KB

Sep 19, 2025

0001493152-25-0143344

Sep 17, 2025

13.3 KB

Sep 19, 2025

0001493152-25-014333

Sep 17, 2025

7.7 KB

SCHEDULE 13D/A

Sep 19, 2025

0001493152-25-014310

—

10.8 KB

25 filings shown

Filed	Form	Description
4/22/25	DEFR14A	DEFR14A	→
4/11/25	DEF 14A	DEF 14A	→
3/31/25	PRE 14A	PRE 14A	→
5/10/24	DEFA14A	DEFA14A	→
4/1/24	DEFA14A	DEFA14A	→
4/1/24	DEF 14A	DEF 14A	→
↓

Aspira Women's Health Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/4/25	4	4	→
12/4/25	4	4	→
12/3/25	4	4	→
12/3/25	4	4	→
12/3/25	4	4	→
12/3/25	4	4	→
↓

Filed	Form	Description
1/9/26	EFFECT	EFFECT	→
11/21/25	EFFECT	EFFECT	→
9/19/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/18/25	D	D	→
5/7/25	EFFECT	EFFECT	→
3/20/25	D	D	→
↓